Cintosh74 · Newsroom
New Low Dose Protease Inhibitor Discovery for HIV-AIDS Treatment
Narhex Australia founding Director and CEO John W. Majewski Looks to Garner Funding Assistance from Indiegogo for the Final Roll Out of His Revolutionary Low Dose Protease Inhibitor for HIV-AIDS Treatment.
October 22, 2014